{"id":"NCT00088153","sponsor":"Massachusetts General Hospital","briefTitle":"Effects of Anorexia Nervosa on Bone Mass in Adolescents","officialTitle":"Effects of Anorexia Nervosa on Peak Bone Mass","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2003-07","primaryCompletion":"2011-02","completion":"2011-06","firstPosted":"2004-07-21","resultsPosted":"2011-10-10","lastUpdate":"2021-11-02"},"enrollment":110,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Anorexia Nervosa"],"interventions":[{"type":"DRUG","name":"Physiologic Estrogen/progesterone","otherNames":["Bone age >=15: Vivelle Dot patch with cyclic Provera"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Physiologic estrogen replacement","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study is to determine the effects of anorexia nervosa on bone mass and hormone levels in adolescents. Whether administration of estrogen, a normal hormone present during puberty, can help maintain bone development in girls with anorexia nervosa will be determined.","primaryOutcome":{"measure":"Percent Change in Spine Bone Density Over the Study Duration (18 Months)","timeFrame":"Baseline and 18 months","effectByArm":[{"arm":"Physiologic Estrogen Replacement","deltaMin":2.6,"sd":1},{"arm":"Placebo","deltaMin":0.3,"sd":0.1}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.05"}]},"eligibility":{"minAge":"12 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":8},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["21698665","24021517","22728230"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":55},"commonTop":["Erythema at patch application site","Bloating","Headaches","Breast tenderness","Nausea/vomiting"]}}